Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study.

[1]  G. Abecasis,et al.  No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38. , 2014, Ophthalmology.

[2]  S. G. Schwartz.  Re: Awh et al.: CFH and ARMS2 Genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration (Ophthalmology 2013;120:2317-23). , 2014, Ophthalmology.

[3]  S. Tsang,et al.  Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines. , 2014, Human molecular genetics.

[4]  Ivana K. Kim,et al.  CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. , 2013, Ophthalmology.

[5]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[6]  Johanna M Seddon,et al.  Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. , 2011, Ophthalmology.

[7]  A. Hofman,et al.  Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and ω-3 fatty acids: the Rotterdam study. , 2011, Archives of ophthalmology.

[8]  Imre Lengyel,et al.  Zinc Binding to the Tyr402 and His402 Allotypes of Complement Factor H: Possible Implications for Age-Related Macular Degeneration , 2011, Journal of molecular biology.

[9]  S. Perkins,et al.  Uncontrolled zinc- and copper-induced oligomerisation of the human complement regulator factor H and its possible implications for function and disease. , 2008, Journal of molecular biology.

[10]  S. Fisher,et al.  Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA , 2008, Nature Genetics.

[11]  J. Ott,et al.  CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. , 2008, Ophthalmology.

[12]  T. Peto,et al.  Cure or cause: opposing roles for zinc in age-related macular degeneration , 2008 .

[13]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[14]  T. Peto,et al.  High concentration of zinc in sub-retinal pigment epithelial deposits. , 2007, Experimental eye research.

[15]  Yun Li,et al.  CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration , 2006, Nature Genetics.

[16]  Johanna M Seddon,et al.  Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.

[17]  Kei Shinoda,et al.  Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Hofman,et al.  Dietary intake of antioxidants and risk of age-related macular degeneration. , 2005, JAMA.

[19]  Robert B Sim,et al.  Oligomeric domain structure of human complement factor H by X-ray and neutron solution scattering. , 1991, Biochemistry.

[20]  A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss: AREDS Report No. 9 , 2001 .

[21]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.